Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance /
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Korporativna značnica: | |
| Drugi avtorji: | |
| Format: | Elektronski eKnjiga |
| Jezik: | angleščina |
| Izdano: |
Hoboken, N.J. :
John Wiley & Sons,
c2009.
|
| Teme: | |
| Online dostop: | An electronic book accessible through the World Wide Web; click to view |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Kazalo:
- The importance of cardiac safety assessments
- The biological basis of adverse drug reactions
- Cardiac structure and function
- Cardiac pathophysiology and disease
- Drug discovery and drug design
- Nonclinical development
- The thorough QT/QTc trial
- General safety assessments
- Therapeutic use trials and meta-analyses
- Assessment methodologies in nonexperimental postmarketing surveillance
- Postmarketing proarrhythmic cardiac safety assessments
- Generalized cardiac safety
- Medication errors, adherence, and concordance
- Future directions in drug safety.